top of page
Timertag Pro label affixed to a routine peripheral IV securement dressing with a user holding a smartphone near the label. A user experience screen is displayed showing patient engagement illustrations for managing their routine peripheral IV, as well as the current dwell time for the peripheral IV. The dwell time is displayed within a yellow screen because the dwell time has now passed 72 hours.
White gaussian blur to highlight the overlying text on webpages.

PATIENT ENGAGEMENT + DWELL TIMES

Tap to Know

Supporting device compliance.

Meet Timertag This October

Association for Vascular Access (AVA) Annual Scientific Meeting (AVASM26)

(Dallas, October 2-4, 2026)

​

The MedTech Conference, Hosted by AdvaMed

(Boston, October 18-21, 2026)

​

ANCC National Magnet Conference and ANCC Pathway to Excellence Conference

(Chicago, October 29-30, 2026)

info@timertag.com

  • LinkedIn

Privacy Policy

​© 2026 Senver Group Pty Ltd ABN 90 622 761 380

Timertag® is a registered trademark of Senver Holdings Pty Ltd in the USA, EU, UK, India, China, Australia, and New Zealand, used under license by Senver Group Pty Ltd (ABN 90 622 761 380).

Timertag Go and Timertag Pro are visual aids at point of care to reinforce standard workflows and simplify frontline operations.  Timertag products do not provide diagnosis or treatment, with classification correspondence available under NDA.  Patent pending.

bottom of page